Clinical Trial Update: Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating relenvatinib for treating recurrence of hepatocellular carcinoma after liver transplantation is listed, with unknown trial s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Relenvatinib (relenvatinib)

Snippet

Sponsor: RenJi Hospital | Conditions: Hepatocellular Carcinoma, Liver Transplantation | Phase 3 | Status: UNKNOWN